Roche Corleen M.

Roche Corleen M. is listed in filings as Chief Financial Officer at Iovance Biotherapeutics, Inc.. This profile follows SEC Form 4 activity through Mar 11, 2026, including 5 public disclosures. Recent filings connect the profile to Iovance Biotherapeutics, Inc. (IOVA) and CG Oncology, Inc. Common stock (CGON). The current snapshot covers public activity from Oct 8, 2024 to Mar 11, 2026. Reported amounts are shown as $774.0K to $3.4M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.